Δ9-Tetrahydrocannabinol Attenuates Allogeneic Host-versus-graft Response And Delays Skin Graft Rejection Through Activation Of Cannabinoid Receptor 1 And Induction Of Myeloid-derived Suppressor Cells

Organ Transplant, Graft Rejection

Key Findings

THC prevents allogeneic host-versus-graft response and delays skin graft rejection via CB1

Information and Links


Link: Δ9-Tetrahydrocannabinol Attenuates Allogeneic Host-versus-graft Response And Delays Skin Graft Rejection Through Activation Of Cannabinoid Receptor 1 And Induction Of Myeloid-derived Suppressor Cells

Year: 2015

DOI: 10.1189/jlb.3A0115-030RR


Ratings

(How Ratings Work)

Organ Transplant, Graft Rejection — 2


Possible to probable range of efficacy of cannabis for treatment of Organ Transplant, Graft Rejection according to the results found in this study.

Drugs Used

THC